Related Experiment Video
Updated: Jan 29, 2026

Simultaneous PET/MRI Imaging During Mouse Cerebral Hypoxia-ischemia
Published on: September 20, 2015
PET imaging in renal cancer.
Liza Lindenberg1, Esther Mena1, Peter L Choyke1
1Molecular Imaging Program, National Cancer Institute, NIH, Bethesda, Maryland, USA.
Positron emission tomography (PET) imaging shows promise for kidney cancer (RCC) detection and prognosis, especially in metastatic cases. Further research into novel molecular tracers is crucial for advancing diagnostic and therapeutic strategies.
Area of Science:
- Oncology
- Nuclear Medicine
- Radiochemistry
Background:
- Kidney cancer (RCC) is a significant global health concern, with limited efficacy of conventional imaging for detection and staging.
- Functional PET/CT imaging offers potential advantages over anatomic imaging in managing RCC, but its role is still developing.
Purpose of the Study:
- To review the current state and future potential of PET imaging agents in the diagnosis and management of renal cell carcinoma (RCC).
- To highlight recent findings and ongoing research in novel PET radiotracers for RCC.
Main Methods:
- Review of current literature on PET imaging in RCC.
- Analysis of various PET radiotracers, including FDG, CAIX, 89Zr-bevacizumab, 89Zr-gerontuximab, FLT, PSMA, 11C-choline, and NaF.
Main Results:
- 18F-fluorodeoxyglucose (FDG) is a key radiotracer, with CAIX imaging showing utility in clear cell RCC.
- Emerging tracers like 89Zr-bevacizumab and 89Zr-gerontuximab show potential for RCC detection and prognosis.
- Differentiating primary RCC from normal tissue remains challenging for most PET tracers.
Conclusions:
- PET/CT imaging, particularly with FDG, is valuable in the metastatic setting and for monitoring treatment response in RCC.
- Continued investigation of innovative molecular tracers is essential for improving RCC diagnostics and therapeutics.
More Related Videos
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Renal Clearance
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
Renal Drug Clearance: Comparison Between Renal Excretion Methods
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
Drug Elimination: Non-Renal Routes
Renal Tubule and Collecting Duct
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...

